Renhe Pharmacy Co., Ltd.

Shenzhen Stock Exchange 000650.SZ

Renhe Pharmacy Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -51.59 M

Renhe Pharmacy Co., Ltd. Net Cash Used For Investing Activities is USD -51.59 M for the year ending December 31, 2023, a 38.10% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Renhe Pharmacy Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -83.35 M, a -265.88% change year over year.
Renhe Pharmacy Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD 50.25 M, a 127.33% change year over year.
Renhe Pharmacy Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -183.85 M, a -48.37% change year over year.
Renhe Pharmacy Co., Ltd. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -123.92 M, a -3,525.06% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Shenzhen Stock Exchange: 000650.SZ

Renhe Pharmacy Co., Ltd.

CEO	Mr. Wujun Huang
IPO Date	Dec. 10, 1996
Location	China
Headquarters	No. 998, Honggu Middle Avenue
Employees	5,792
Sector	Healthcare
Industries Pharmaceuticals Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care

Description

Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, topical lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.

Key trends

Past 5 years